Role of SGLT-2 Inhibitors in Treatment of Patients with Type 2 Diabetes and NAFLDJournal: International Journal of Clinical Dermatology & Research (IJCDR) (Vol.10, No. 01)
Publication Date: 2022-02-18
Authors : Nasser Mikhail;
Page : 279-283
Keywords : Fatty Liver; Sodium-Glucose Cotransporter-2 Inhibitors; Diabetes; Liver Biopsy;
Background: The role of sodium-glucose cotransporters-2 (SGLT-2) inhibitors in treatment of non-alcoholic fatty liver disease (NAFLD) is unclear. Objective: To examine the possible therapeutic role of SGLT-2 inhibitors in patients with type 2 diabetes and NAFLD. Methods: Pubmed search of English literature up to February 17, 2022. Search terms are fatty liver, SGLT-2, sodium-glucose cotransporter-2 inhibitors, diabetes, weight loss, liver biopsy. Randomized studies are reviewed with focus placed on doubleblind, placebo-controlled trials. Meta-analyses and pertinent reviews are also included.
Other Latest Articles
Last modified: 2022-04-13 21:14:09